Institutional investors purchased a net $6.9 million shares of ABBV during the quarter ended March 2016 and now own 70.34% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STANDARD LIFE INVESTMENTS LTD. Bought 536.4 Thousand shares of AbbVie
3 BANKEN-GENERALI INVESTMENT-GES... Bought 144.9 Thousand shares of AbbVie
STATE STREET GLOBAL ADVISORS LTD... Bought 73.8 Thousand shares of AbbVie